9 Documents disponibles dans cette série
"EU Drug Market: Amphetamine" describes the European amphetamine market from production and trafficking, to distribution and use. It details the processes, materials and actors involved at different stages and levels of the market. Taking a thre[...]
'EU Drug Market: Cannabis' describes the European cannabis market from production and trafficking, to distribution and use. It details the processes, materials and players involved at different stages and levels of the market. The module takes a[...]
In this new report, "EU Drug Markets: Drivers and facilitators", the EMCDDA and Europol, provide valuable insights into the evolving landscape of drug production, trafficking and distribution. The report is a key element in the "EU Drug Markets:[...]
What are the latest changes in the EU opioids market? How are global geopolitical developments impacting supply? Are heroin trafficking routes changing? To what extent do synthetic opioids pose a threat to Europe? These are among the issues expl[...]
What effect is COVID-19 having on the drug market in the EU? This joint publication from the EMCDDA and Europol analyses the impact of the pandemic on the market for the main drug types (cannabis, heroin, cocaine, amphetamines, NPS), including d[...]
"EU Drug Market: MDMA" describes the European MDMA market from production to trafficking, distribution and use. It details the materials, processes and players involved at different stages and levels of the market. The module takes a threat asse[...]
The EU market for new psychoactive substances (NPS) is highly dynamic and resilient, characterised by a high turnover of potent, cheap and available substances. The analysis describes the European market for NPS, from production and traffickin[...]
Historique
